Colorectal Cancer: FOLFOX versus FOLFIRI in the MAVERICC Trial
Follow
The panelists, John L. Marshall, MD; Johanna Bendell, MD; Charles S. Fuchs, MD, MPH; Tanios BekaiiSaab, MD; and Richard Kim, MD, discuss how they decide between the chemotherapy regimens FOLFOX and FOLFIRI in colorectal cancer.